Kristina Levan

607 total citations
17 papers, 463 citations indexed

About

Kristina Levan is a scholar working on Reproductive Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Kristina Levan has authored 17 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Kristina Levan's work include Ovarian cancer diagnosis and treatment (13 papers), Reproductive Biology and Fertility (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Kristina Levan is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Reproductive Biology and Fertility (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Kristina Levan collaborates with scholars based in Sweden. Kristina Levan's co-authors include Karolina Partheen, Lovisa Österberg, Karin Sundfeldt, György Horváth, Björg Kristjánsdóttir, Khalil Helou, Björn Olsson, Elisabet Carlsohn, G. Horváth and Ulla Delle and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Kristina Levan

17 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Levan Sweden 14 223 178 150 106 63 17 463
Lindsay Bergan United States 9 157 0.7× 425 2.4× 106 0.7× 102 1.0× 93 1.5× 12 655
John B. Beard United States 7 302 1.4× 106 0.6× 63 0.4× 110 1.0× 168 2.7× 8 513
Marilisa Cargnelutti Italy 9 270 1.2× 62 0.3× 132 0.9× 221 2.1× 95 1.5× 10 521
Grażyna Ewa Będkowska Poland 13 166 0.7× 92 0.5× 190 1.3× 171 1.6× 117 1.9× 29 433
Cindy A. Pise-Masison United States 5 497 2.2× 371 2.1× 320 2.1× 158 1.5× 76 1.2× 6 820
Robert L. Hollis United Kingdom 15 255 1.1× 431 2.4× 138 0.9× 256 2.4× 68 1.1× 32 695
Yinhua Yu China 8 284 1.3× 84 0.5× 108 0.7× 176 1.7× 33 0.5× 10 465
Karolina Partheen Sweden 13 227 1.0× 235 1.3× 168 1.1× 96 0.9× 61 1.0× 18 499
Nirupa Murugaesu United Kingdom 10 277 1.2× 167 0.9× 197 1.3× 185 1.7× 66 1.0× 16 648
Diana P. English United States 14 140 0.6× 98 0.6× 43 0.3× 232 2.2× 49 0.8× 24 447

Countries citing papers authored by Kristina Levan

Since Specialization
Citations

This map shows the geographic impact of Kristina Levan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Levan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Levan more than expected).

Fields of papers citing papers by Kristina Levan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Levan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Levan. The network helps show where Kristina Levan may publish in the future.

Co-authorship network of co-authors of Kristina Levan

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Levan. A scholar is included among the top collaborators of Kristina Levan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Levan. Kristina Levan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Ebefors, Kerstin, et al.. (2016). Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1. BMC Nephrology. 17(1). 40–40. 25 indexed citations
3.
Kristjánsdóttir, Björg, Karolina Partheen, Eric T. Fung, et al.. (2014). Early inflammatory response in epithelial ovarian tumor cyst fluids. Cancer Medicine. 3(5). 1302–1312. 12 indexed citations
4.
Kristjánsdóttir, Björg, Kristina Levan, Karolina Partheen, & Karin Sundfeldt. (2013). Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer. Gynecologic Oncology. 131(1). 52–58. 62 indexed citations
5.
Kristjánsdóttir, Björg, Kristina Levan, Karolina Partheen, Elisabet Carlsohn, & Karin Sundfeldt. (2013). Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ. Clinical Proteomics. 10(1). 4–4. 33 indexed citations
6.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, et al.. (2010). Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma. Gene Expression. 14(6). 361–370. 11 indexed citations
7.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2010). Specific copy number alterations associated with docetaxel/carboplatin response in ovarian carcinomas.. PubMed. 30(11). 4451–8. 10 indexed citations
8.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer. 9(1). 368–368. 27 indexed citations
9.
Partheen, Karolina, et al.. (2009). External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas. BMC Cancer. 9(1). 336–336. 15 indexed citations
10.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma. Cytogenetic and Genome Research. 125(1). 8–18. 15 indexed citations
11.
Samuelson, Emma, Kristina Levan, Tatjana Adamović, Göran Levan, & György Horváth. (2008). Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 181(1). 25–30. 17 indexed citations
12.
Partheen, Karolina, et al.. (2008). Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. International Journal of Cancer. 123(9). 2130–2137. 66 indexed citations
13.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, Khalil Helou, & G. Horváth. (2006). Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization. Cytogenetic and Genome Research. 115(1). 16–22. 20 indexed citations
14.
Österberg, Lovisa, et al.. (2006). Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Cancer Genetics and Cytogenetics. 167(2). 103–108. 13 indexed citations
15.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, & György Horváth. (2006). Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. European Journal of Cancer. 42(16). 2846–2854. 44 indexed citations
16.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, Khalil Helou, & György Horváth. (2005). Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cancer Genetics and Cytogenetics. 163(2). 144–150. 25 indexed citations
17.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, Khalil Helou, & György Horváth. (2004). Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes Chromosomes and Cancer. 40(4). 342–348. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsay Bergan Breakdown of academic impact, for papers by John B. Beard Breakdown of academic impact, for papers by Marilisa Cargnelutti Breakdown of academic impact, for papers by Grażyna Ewa Będkowska Breakdown of academic impact, for papers by Cindy A. Pise-Masison Breakdown of academic impact, for papers by Robert L. Hollis Breakdown of academic impact, for papers by Yinhua Yu Breakdown of academic impact, for papers by Karolina Partheen Breakdown of academic impact, for papers by Nirupa Murugaesu Breakdown of academic impact, for papers by Diana P. English
Rankless by CCL
2026